Difference between revisions of "Fleishman-Hillard"
(→External Resources) |
Tamasin Cave (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Global operation== | ==Global operation== | ||
| − | Fleishman-Hillard operates | + | Headquartered in St. Louis, Fleishman-Hillard has over 80 offices throughout North America, Europe, Asia Pacific, Middle East, South Africa, and Latin America. It operates through a variety of networks: |
*[[Allyn & Company]] | *[[Allyn & Company]] | ||
*[[Fleishman-Hillard Government Relations]] | *[[Fleishman-Hillard Government Relations]] | ||
| Line 14: | Line 14: | ||
*[[VOX Global Mandate]] | *[[VOX Global Mandate]] | ||
| − | ==UK | + | |
| + | ==UK operation== | ||
| + | Fleishman-Hillard has 3 offices in the UK: London, [[Edinburgh|Fleishman-Hillard (Edinburgh)]] and Dublin. | ||
In April 2005 Kevin Maguire wrote of F-H distributing a glossy brochure to their clients sketching the likely changes that could be expected under a Labour government led by Gordon Brown. "Warning multinational bosses that the next Labour premier's philosophy is built on - wait for it - equity, the booklet predicts Brown will centralise power around himself," Maguire wrote.<ref>[http://www.newstatesman.com/200504180015]</ref> | In April 2005 Kevin Maguire wrote of F-H distributing a glossy brochure to their clients sketching the likely changes that could be expected under a Labour government led by Gordon Brown. "Warning multinational bosses that the next Labour premier's philosophy is built on - wait for it - equity, the booklet predicts Brown will centralise power around himself," Maguire wrote.<ref>[http://www.newstatesman.com/200504180015]</ref> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==Clients== | ==Clients== | ||
*government of Turkey | *government of Turkey | ||
| + | |||
===Scotland=== | ===Scotland=== | ||
[[Nirex]] | [[Nirex]] | ||
[[Pfizer]] | [[Pfizer]] | ||
| + | |||
| + | ==Specific lobbying campaigns== | ||
| + | ===Biotech=== | ||
| + | In 2003, it was reported that “Fleishman-Hillard has been getting more and more deeply involved in the biotechnology sector, helping the Biotechnology Industry Organisation and the Council of Biotechnology Information communicate the benefits of the technology to consumers and opinion leaders.” In April 2006, US biotechnology firm Genzyme appointed Fleishman-Hillard to boost its profile among British policymakers and lobby the UK Government to commit more funding to biotech.<ref>[http://www.sourcewatch.org/index.php?title=Fleishman-Hillard Holmes Report]</ref>;<ref>PR Week, “F-H Wins UK Job for Biotech Genzyme”, April 14, 2006, p7</ref> | ||
| + | |||
| + | ===Turkey=== | ||
| + | On 10 October 2007, the US House of Representatives Committee on Foreign Affairs passed Resolution 106, which accuses the Turkish rulers in 1915 of genocide. There was an intensive on behalf of the Turkish government to sway the committee, described by Ali H. Aslan as follows: | ||
| + | :Both the Turkish and the US governments strongly opposed the resolution and were joined by DLA Piper, the Livingstone Group, public relations company '''Fleishman-Hillard''' and other companies that officially conducted lobbying activities on behalf of Turkey as well as by big corporations that have sizable commercial deals with Turkey such as Boeing and BP.<ref>Ali H. Aslan, [http://www.todayszaman.com/tz-web/detaylar.do?load=print&link=124570&yazarAd= How did last-minute hopes turn into disappointment?], Zaman, 10 October 2007.</ref> | ||
| + | |||
| + | ===ID cards=== | ||
| + | In June 2005, [[Kevin Bell]] from the UK arm of Fleishman-Hillard spoke at a one-day conference in London called [[ID Cards: Towards Procurement and Implementation]]. The title of his talk was "Achieving public acceptance".<ref>[http://www.intellectuk.org/events/id_agenda160305.pdf]</ref> | ||
| + | |||
==People== | ==People== | ||
*[[Kevin Bell]] | [[Paul Borge]] | *[[Kevin Bell]] | [[Paul Borge]] | ||
| + | |||
| + | ==Contacts== | ||
| + | 40 Long Acre, London WC2 <br> | ||
| + | www.fleishman-hillard.co.uk | ||
| + | |||
| + | |||
==External Resources== | ==External Resources== | ||
*[[GPC International UK Staff and Clients 1.12.03 to 31.5.04]] | *[[GPC International UK Staff and Clients 1.12.03 to 31.5.04]] | ||
| Line 49: | Line 57: | ||
[[Category:Lobbying firms]] | [[Category:Lobbying firms]] | ||
[[Category:Food lobbyists and PR consultants]] | [[Category:Food lobbyists and PR consultants]] | ||
| + | [[Category: Financial sector lobbying]] | ||
Revision as of 14:34, 17 February 2009
Contents
Background
Fleishman-Hillard [1] is one of the biggest PR companies in the world with over 80 offices worldwide. Its parent company is the Omnicom group Inc [2], which is a huge conglomerate that describes itself as a "global leader in Marketing and Global Communications". It has absorbed the group of firms formerly trading under the name GPC International
Global operation
Headquartered in St. Louis, Fleishman-Hillard has over 80 offices throughout North America, Europe, Asia Pacific, Middle East, South Africa, and Latin America. It operates through a variety of networks:
- Allyn & Company
- Fleishman-Hillard Government Relations
- GPC Public Affairs
- GMMB
- Mercury Public Affairs
- Strat@comm
- VOX Global Mandate
UK operation
Fleishman-Hillard has 3 offices in the UK: London, Fleishman-Hillard (Edinburgh) and Dublin. In April 2005 Kevin Maguire wrote of F-H distributing a glossy brochure to their clients sketching the likely changes that could be expected under a Labour government led by Gordon Brown. "Warning multinational bosses that the next Labour premier's philosophy is built on - wait for it - equity, the booklet predicts Brown will centralise power around himself," Maguire wrote.[1]
Clients
- government of Turkey
Scotland
Specific lobbying campaigns
Biotech
In 2003, it was reported that “Fleishman-Hillard has been getting more and more deeply involved in the biotechnology sector, helping the Biotechnology Industry Organisation and the Council of Biotechnology Information communicate the benefits of the technology to consumers and opinion leaders.” In April 2006, US biotechnology firm Genzyme appointed Fleishman-Hillard to boost its profile among British policymakers and lobby the UK Government to commit more funding to biotech.[2];[3]
Turkey
On 10 October 2007, the US House of Representatives Committee on Foreign Affairs passed Resolution 106, which accuses the Turkish rulers in 1915 of genocide. There was an intensive on behalf of the Turkish government to sway the committee, described by Ali H. Aslan as follows:
- Both the Turkish and the US governments strongly opposed the resolution and were joined by DLA Piper, the Livingstone Group, public relations company Fleishman-Hillard and other companies that officially conducted lobbying activities on behalf of Turkey as well as by big corporations that have sizable commercial deals with Turkey such as Boeing and BP.[4]
ID cards
In June 2005, Kevin Bell from the UK arm of Fleishman-Hillard spoke at a one-day conference in London called ID Cards: Towards Procurement and Implementation. The title of his talk was "Achieving public acceptance".[5]
People
Contacts
40 Long Acre, London WC2
www.fleishman-hillard.co.uk
External Resources
- GPC International UK Staff and Clients 1.12.03 to 31.5.04
- Fleishman-Hillard UK Staff and Clients 31.11.04 to 31.5.05
- Fleishman-Hillard, PRCA Yearbook 2004
- Fleishman-Hillard UK Staff and Clients 1 June 2005 to 30 Nov 2005
- Fleishman-Hillard UK Staff and Clients 1 December 2007 to 29 February 2008
